ScoreWhy is BioMarin Pharmaceutical, Inc. ?
1
Negative results in Mar 26
- INTEREST COVERAGE RATIO(Q) Lowest at 1,114.96
- PRE-TAX PROFIT(Q) At USD 149.52 MM has Fallen at -31.14%
- NET PROFIT(Q) At USD 111.74 MM has Fallen at -38.48%
2
With ROE of 11.94%, it has a very expensive valuation with a 1.71 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 4.47%, its profits have risen by 65.4% ; the PEG ratio of the company is 0.2
3
Underperformed the market in the last 1 year
- The stock has generated a return of 4.47% in the last 1 year, much lower than market (S&P 500) returns of 22.24%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is BioMarin Pharmaceutical, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
BioMarin Pharmaceutical, Inc.
4.47%
-0.89
35.88%
S&P 500
22.24%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.97%
EBIT Growth (5y)
57.15%
EBIT to Interest (avg)
11.59
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.44
Tax Ratio
22.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.46%
ROE (avg)
7.17%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.71
EV to EBIT
11.57
EV to EBITDA
10.55
EV to Capital Employed
1.84
EV to Sales
2.92
PEG Ratio
0.22
Dividend Yield
NA
ROCE (Latest)
15.92%
ROE (Latest)
11.94%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 874.24 MM
CASH AND EQV(HY)
Highest at USD 3,783.04 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 0.61 times
-21What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 1,114.96
PRE-TAX PROFIT(Q)
At USD 149.52 MM has Fallen at -31.14%
NET PROFIT(Q)
At USD 111.74 MM has Fallen at -38.48%
RAW MATERIAL COST(Y)
Grown by 6.3% (YoY
INTEREST(Q)
Highest at USD 14.96 MM
Here's what is working for BioMarin Pharmaceutical, Inc.
Operating Cash Flow
Highest at USD 874.24 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 3,783.04 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 0.61 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for BioMarin Pharmaceutical, Inc.
Interest
At USD 14.96 MM has Grown at 438.44%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest Coverage Ratio
Lowest at 1,114.96
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Pre-Tax Profit
At USD 149.52 MM has Fallen at -31.14%
over average net sales of the previous four periods of USD 217.12 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD 111.74 MM has Fallen at -38.48%
over average net sales of the previous four periods of USD 181.63 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
Highest at USD 14.96 MM
in the last five periods and Increased by 438.44% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Raw Material Cost
Grown by 6.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
